These pages, marked with GREEN headings,
are published for comment
and criticism. These are not our final findings; some of these opinions
will probably change.LOG OF UPDATES
Overview
of all studies: Because of the largely unexpected transformational
power of molecular manufacturing, it is urgent to understand the issues
raised. To date, there has not been anything approaching an adequate
study of these issues. CRN's recommended series of thirty essential
studies is organized into five sections, covering fundamental theory,
possible technological capabilities, bootstrapping potential, product
capabilities, and policy questions. Several preliminary conclusions
are stated, and because our understanding points to a crisis, a parallel
process of conducting the studies is urged. Download
complete PDF(443kb)
CRN is actively
looking for researchers interested in performing or assisting with this
work. Please contact CRN Research Director Chris
Phoenix if you would like more information or if you have comments
on the proposed studies.
NOTE:
We are completely dependent on small grants and individual contributions.
If you want this dialogue and research to keep moving ahead, we need your
help! Donations to CRN are deductible as charitable contributions for income
tax purposes.
Understanding
molecular manufacturing is urgent.
CRN believes
it is urgent to understand several issues related to molecular
manufacturing (MM), to prepare for its possible development sometime
in the next decade. The technology will be more transformative than
most people expect, and could develop too
rapidly for reactive policy to succeed. MM is the result of convergence
of many technologies, and will benefit from synergies between them.
It will be more powerful than most people will be able to comprehend
without serious study.
Molecular manufacturing,
along with other technologies that it will enhance or enable, will create new
problems and new
opportunities that require new
solutions. To date, there has not been anything approaching
an adequate study of these issues. This series of pages presents
some of these issues in the form of thirty recommended studies.
CRN’s preliminary answers are included to reinforce the relevance
and urgency of the investigation.
The
30 studies are organized into five sections.
The studies
are organized in several sections. The first
section covers the fundamental theory: insights that may be counterintuitive
or unobvious and need explanation, but that can be double-checked by
simple thought. The second
section addresses technological capabilities of possible molecular
manufacturing technologies. The third
section addresses 'bootstrapping'—the development of the
first self-contained molecular manufacturing system (which will
then be able to produce duplicates at an exponential rate), including
schedule considerations. The fourth
section explores the capabilities of products, building toward
the fifth
section, which raises serious questions about policies and
policymaking.
CRN's
preliminary conclusions.
To begin this
iterative process, we have supplied provisional answers to each study,
with supporting data where available. Several preliminary conclusions
should be noted here:
Programmable
positional chemistry, with the ability to fabricate nanocomponents,
can be the basis of an extremely powerful manufacturing technology.
The importance of this is substantially unrecognized.
Development
of molecular manufacturing may be imminent, depending on whether
any of several actors has begun investigating it already. We believe
that a program started today, even outside the United States, could
finish in under a decade, including development of a substantial
product design capability.
Development
activity may be very difficult to detect.
Several
considerations, including economics and product sophistication,
point to MM being a transformative, disruptive, destabilizing, and
potentially dangerous technology.
Although
the technology may be quite dangerous, avoidance and prevention
are not viable options. Simple attempts to dominate or control the
capability will also be unworkable.
MM will
also have many productive uses, and policy must account for the
global-scale problems it can solve as well as a possible high level
of civilian demand/utilization.
Policymaking
and preparation will be complex and difficult, and will require
substantial time.
Section
One:
Technical
and Foundational
This section
covers the fundamental theory behind molecular nanotechnology manufacturing:
insights that may be counterintuitive or unobvious and need explanation,
but that can be double-checked by simple thought.
Capabilities
of Molecular Manufacturing Technologies
Molecular manufacturing
(MM) is the use of programmable chemistry to make programmable products,
including duplicate manufacturing systems. Programmability implies automation,
and duplication implies low capital cost. MM may drastically reduce the
cost of both products and manufacturing capacity. In addition, precise
control of chemistry should produce very strong structure and very compact
functionality. High performance products imply high performance manufacturing.
Quantifying these advantages is necessary to understand the impact and
desirability of MM.
This section
suggests metrics for manufacturing and product capability. The following
studies should be run for each plausible molecular manufacturing technology.
These questions will be answered for diamondoid systems
based on the Phoenix
nanofactory design.
This section
assumes the existence of a general-purpose molecular manufacturing system.
It suggests problems and opportunities raised by molecular manufacturing,
and hints at the difficulties of making policy to deal with them. The
answers in this section, as in the previous section, assume a diamondoid nanofactory
technology.
The situation
is extremely urgent. The stakes are unprecedented, and the world is unprepared.
The basic findings of these studies should be verified as rapidly as possible
(months, not years). Policy preparation and planning for implementation,
likely including a crash development program, should begin immediately.
DEVIL'S ADVOCATE —
(Sorry, no one has complained about this page yet, and we
couldn't think of anything to write. Please contact
us with your questions, criticisms, and other
suggestions.)